Contract # SPM2D013D0005
    PSC 6505 Drugs And Biologicals
    Set-Aside None
    Status Past Ordering Date
    POP 5/22/13 - 5/21/14 (11 months)
  • Aggregate Dollars Obligated

    $1.5m

  • Aggregate Base & Exercised Options Value

    $1.5m

  • Aggregate Ceiling

    $1.5m

  • Pricing Type

    Firm Fixed Price

  • Single or Multiple Award

    Single Award

  • Extent Competed

    Full and Open Competition, 1 offer(s)

Agency Contract # Vendor NAICS PSC Set-Aside Last Active Kickoff Completion Ceiling % Ob.
DLA SPM2D013D0005-0069 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 None 5/18/17 5/18/17 5/30/17
  • 4538071314!CLONAZEPAM TABLETS USP 0.5 MG 100S BT
DLA SPM2D013D0005-0068 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 None 5/11/17 5/11/17 5/22/17
  • 4537999739!DIAZEPAM TABLETS USP, 5 MG, 100 TABLETS
DLA SPM2D013D0005-0067 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 None 5/8/17 5/8/17 5/17/17
  • 4537943314!CLONAZEPAM TABLETS USP 0.5 MG 100S BT
DLA SPM2D013D0005-8004 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 None 5/3/17 5/3/17 5/21/18
  • !
DLA SPM2D013D0005-0066 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 None 4/21/17 4/21/17 4/21/17
  • 4537769443!CLONAZEPAM TABLETS USP 0.5 MG 100S BT